Fernando Escobar Jiménez-rekin lankidetzan egindako argitalpenak (17)

1998

  1. Hyperfuncion tiroidea y masa osea

    Revista Espanola de Enfermedades Metabolicas Oseas

1997

  1. Antiresorptive Therapy in Hyperthyroid Patients: Longitudinal Changes in Bone and Mineral Metabolism

    Journal of Clinical Endocrinology and Metabolism, Vol. 82, Núm. 6, pp. 1989-1994

  2. Association between congenital adrenal hyperplasia resulting from 21- hydroxylase deficiency and bilateral testicular tumors: A report of two cases

    Endocrinologist, Vol. 7, Núm. 1, pp. 65-68

  3. Bone loss in hyperthyroid patients and in former hyperthyroid patients controlled on medical therapy: Influence of aetiology and menopause

    Clinical Endocrinology, Vol. 47, Núm. 3, pp. 279-285

  4. Identification of metabolic bone disease in patients with endogenous hyperthyroidism: Role of biological markers of bone turnover

    Calcified Tissue International, Vol. 61, Núm. 5, pp. 370-376

1996

  1. Bone mineral density measured by dual X-ray absorptiometry in Spanish patients with insulin-dependent diabetes mellitus

    Calcified Tissue International, Vol. 58, Núm. 5, pp. 316-319

1995

  1. Bone mass in androgen-insensitivity syndrome: Response to hormonal replacement therapy

    Calcified Tissue International, Vol. 57, Núm. 2, pp. 94-96

  2. Elevación de enzimas musculares e hipoparatiroidismo idiopático.

    Medicina Clinica

  3. Ketoconazole therapy: Hormonal and clinical effects in non-tumoral hyperandrogenism

    Obstetrical and Gynecological Survey, Vol. 50, Núm. 1, pp. 42-44

1994

  1. Bone mineral density is decreased in hyperthyroidism.

    Clinical Endocrinology

  2. Hyperinsulinemia in polycystic ovary syndrome: relationship to clinical and hormonal factors

    The Clinical Investigator, Vol. 72, Núm. 11, pp. 853-857

  3. ILEO ADINAMICO ASOCIADO A MIXEDEMA PROGRESIVO POR CRETINISMO

    Endocrinologia, Vol. 41, Núm. 1, pp. 17-19

  4. Ketoconazole therapy: Hormonal and clinical effects in non-tumoral hyperandrogenism

    European Journal of Endocrinology, Vol. 130, Núm. 4, pp. 333-338

  5. Letters to the editors [1]

    Clinical Endocrinology

  6. Reduction of endogenous, ovarian and adrenal androgens with ketoconazole does not alter insulin response in the polycystic ovary syndrome

    Journal of Endocrinological Investigation, Vol. 17, Núm. 8, pp. 647-652

1993

  1. PERFIL LIPIDICO DE LA PACIENTE HIPERANDROGENICA EN TRATAMIENTO CON KETOCONAZOL Y SU RELACION CON LA EVOLUCION DEL PATRON HORMONAL

    Medicina Clinica, Vol. 101, Núm. 20, pp. 766-768

  2. Técnicas de localización en el hiperparatiroidismo primario.

    Medicina Clinica